Ki-Hyun Kim

Title: Innovations and Achievements of Ki-Hyun Kim

Introduction

Ki-Hyun Kim, based in Gyeonggi-do, South Korea, is a prominent inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 101 patents, he has made substantial strides in developing innovative therapeutic solutions, particularly in cancer treatment.

Latest Patents

Among his latest inventions are groundbreaking patents involving natural killer (NK) cells and chimeric antigen receptors (CARs). One notable patent, titled "Natural Killer Cell Expressing Anti-Cotinine Chimeric Antigen Receptor," discloses an NK cell capable of specifically binding to cotinine. This innovative approach allows the NK cell to effectively target tumor tissues across various types of cancers, providing an efficient gene therapy with anticancer effects.

Another significant patent titled "Chimeric Antigen Receptor to Which Anti-Cotinine Antibody Is Linked" showcases a chimeric antibody receptor that interacts with cotinine. This development involves T cells that secrete interferon gamma to induce the death of cells expressing the targeted molecule. Additionally, the patent suggests administering a cytotoxic agent conjugated with cotinine to manage any hyperactivity of the T cells, ensuring a balanced and safe cancer treatment strategy.

Career Highlights

Ki-Hyun Kim has had a distinguished career in the research and development sector, working for reputable companies such as Samsung Electronics Co., Ltd. and Samsung SDI Co., Inc. His roles in these organizations have allowed him to refine his innovative skills and contribute to various high-impact projects.

Collaborations

Throughout his career, Ki-Hyun Kim has collaborated with fellow researchers and inventors, including Se-Ho Park and Sung-Kweon Park. These collaborations have enhanced the quality and scope of his work, fostering a creative environment for developing impactful technologies.

Conclusion

In summary, Ki-Hyun Kim stands out as an influential inventor in the biotechnology field, particularly in cancer treatment innovations. His extensive patent portfolio and collaborative efforts highlight his dedication to advancing medical technology and improving patient outcomes.